JP2023510544A5 - - Google Patents

Info

Publication number
JP2023510544A5
JP2023510544A5 JP2022542413A JP2022542413A JP2023510544A5 JP 2023510544 A5 JP2023510544 A5 JP 2023510544A5 JP 2022542413 A JP2022542413 A JP 2022542413A JP 2022542413 A JP2022542413 A JP 2022542413A JP 2023510544 A5 JP2023510544 A5 JP 2023510544A5
Authority
JP
Japan
Application number
JP2022542413A
Other languages
Japanese (ja)
Other versions
JPWO2021142212A5 (https=
JP7696909B2 (ja
JP2023510544A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/012630 external-priority patent/WO2021142212A1/en
Publication of JP2023510544A publication Critical patent/JP2023510544A/ja
Publication of JPWO2021142212A5 publication Critical patent/JPWO2021142212A5/ja
Publication of JP2023510544A5 publication Critical patent/JP2023510544A5/ja
Priority to JP2025097871A priority Critical patent/JP2025124904A/ja
Application granted granted Critical
Publication of JP7696909B2 publication Critical patent/JP7696909B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022542413A 2020-01-09 2021-01-08 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法 Active JP7696909B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025097871A JP2025124904A (ja) 2020-01-09 2025-06-11 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US202062958809P 2020-01-09 2020-01-09
US202062958827P 2020-01-09 2020-01-09
US62/958,809 2020-01-09
US62/958,827 2020-01-09
US202062967242P 2020-01-29 2020-01-29
US202062967104P 2020-01-29 2020-01-29
US62/967,242 2020-01-29
US62/967,104 2020-01-29
US202063064506P 2020-08-12 2020-08-12
US202063064571P 2020-08-12 2020-08-12
US63/064,506 2020-08-12
US63/064,571 2020-08-12
US202063112202P 2020-11-11 2020-11-11
US202063112219P 2020-11-11 2020-11-11
US63/112,219 2020-11-11
US63/112,202 2020-11-11
PCT/US2021/012630 WO2021142212A1 (en) 2020-01-09 2021-01-08 Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025097871A Division JP2025124904A (ja) 2020-01-09 2025-06-11 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法

Publications (4)

Publication Number Publication Date
JP2023510544A JP2023510544A (ja) 2023-03-14
JPWO2021142212A5 JPWO2021142212A5 (https=) 2023-10-31
JP2023510544A5 true JP2023510544A5 (https=) 2023-10-31
JP7696909B2 JP7696909B2 (ja) 2025-06-23

Family

ID=74505354

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022542413A Active JP7696909B2 (ja) 2020-01-09 2021-01-08 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法
JP2025097871A Pending JP2025124904A (ja) 2020-01-09 2025-06-11 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025097871A Pending JP2025124904A (ja) 2020-01-09 2025-06-11 ヘルペスウイルス糖タンパク質dと融合したb型肝炎ウイルス抗原をコードするアデノウイルスベクター及びその使用方法

Country Status (13)

Country Link
US (5) US12605444B2 (https=)
EP (1) EP4087605A1 (https=)
JP (2) JP7696909B2 (https=)
KR (1) KR20220163354A (https=)
CN (2) CN115335076B (https=)
AU (1) AU2021205936A1 (https=)
BR (1) BR112022013620A2 (https=)
CA (1) CA3166989A1 (https=)
IL (1) IL294387A (https=)
MX (1) MX2022008572A (https=)
PH (1) PH12022551648A1 (https=)
WO (1) WO2021142212A1 (https=)
ZA (1) ZA202310905B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL294387A (en) * 2020-01-09 2022-08-01 Virion Therapeutics Llc Adenovirus vectors encoding hepatitis b virus antigens fused to herpesvirus glycoprotein d and methods of using them

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070054262A1 (en) 2003-03-28 2007-03-08 Baker Denise M Methods of identifying optimal variants of peptide epitopes
US20090246220A1 (en) * 2006-08-28 2009-10-01 Ertl Hildegund C J Constructs for enhancing immune responses
EA028659B1 (ru) * 2011-02-12 2017-12-29 Глоубиммьюн, Инк. Терапевтическое средство на основе дрожжей для лечения хронического гепатита b
GB201223386D0 (en) * 2012-12-24 2013-02-06 Immune Targeting Systems Its Ltd Vaccine
EP2959915A1 (en) * 2014-06-23 2015-12-30 Institut Pasteur A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
CN105367662B (zh) * 2014-08-29 2021-03-12 汤正好 一种hbv相关的融合蛋白、其制备方法及其应用
US11324819B2 (en) 2016-04-06 2022-05-10 University Of Washington Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen
SG11201900808SA (en) 2016-08-01 2019-02-27 Wistar Inst Compositions and methods of replication deficient adenoviral vectors for vaccine applications
CN119770638A (zh) * 2019-09-30 2025-04-08 吉利德科学公司 Hbv疫苗和治疗hbv的方法
IL294387A (en) * 2020-01-09 2022-08-01 Virion Therapeutics Llc Adenovirus vectors encoding hepatitis b virus antigens fused to herpesvirus glycoprotein d and methods of using them

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021015500A2 (https=)
CH718816A4 (https=)
JP2023510544A5 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)